The omicron variant threatens to widen an already huge gap in access to covid vaccines as scientists are bracing for the possibility that repurposed vaccines are needed and rich countries once again rush to get them first. The omicron variant emerges just as vaccine supplies destined for low-income countries begin to rebound. At the start […]
Tag: Pfizer
Pfizer predicts vaccine will work for omicron variant
Updated on 03/12/2021 03:59 am Pfizer expects its COVID-19 vaccine to be effective against the omicron variant, an executive said, and data on how well it protects should be available within two to three weeks. “We do not expect there to be a significant drop in effectiveness,” Ralf Rene Reinert, vice president of vaccines for […]
COVID-19: Delta variant may have greater ability to evade immunity from vaccines
Updated on 02/12/2021 05:30 pm The delta variant of SARS-CoV-2 may be more successful in evading the protective response of vaccines from Pfizer and AstraZeneca, indicates a study that does not include the new omicron and published by Plos. A team of British scientists, led by the University of Glasgow, did an analysis to quantify […]
Study concludes that combining Sinovac and Pfizer vaccines is safe
The third booster dose applied by the Dominican Republic with Pfizer serum, combined with two doses of Sinovac vaccine, is “safe” and “does not produce major events”, According to the results of a study on this issue presented in the country. Research on the effectiveness of the booster dose, conducted between the Dominican Republic and […]
Pfizer could have a new vaccine against the omicron variant in 100 days
Updated on 11/30/2021 11:24 am In a period of 100 days, a vaccine could be developed against the new omicron variant of COVID-19, said the president and director of Pfizer Spain Sergio Rodríguez Márquez during his statements in the Congress of Deputies. Before the Investigation Committee on the management of vaccines and the Vaccination Plan, […]
Pfizer has already started work on a version of the COVID vaccine against omicron
Updated on 11/29/2021 11:59 am Pfizer It has already started working on a new version of its anti-COVID vaccine aimed more specifically at the omicron variant, in case the current immunizer is not sufficiently effective against this variation, assured the executive director of the American pharmaceutical company, Albert Bourla. “There are still many things that […]
Pfizer expects to produce 80 million pill treatments for COVID-19
Updated on 11/29/2021 10:36 am Pfizer Inc. expects to manufacture 80 million treatments of its experimental antiviral drug for COVID-19, up from a previous forecast of 50 million, announced its CEO Albert Bourla. Earlier this month, Pfizer said it expects to make 180,000 treatments by the end of this year and at least 50 million […]
Pfizer-BioNTech will have data on vaccine efficacy against new variant “in two weeks”
Updated on 11/26/2021 08:43 am The German laboratory BioNTech announced that it was urgently studying the efficacy of the COVID-19 vaccine it developed with Pfizer to see if it protects against the new B.1.1.529 variant detected in South Africa. “We expect more data from laboratory tests in two weeks maximum”Said a spokesperson. “These data will […]
Moderna and Sputnik Vaccines outperform Pfizer in Hungarian study
The COVID-19 vaccines from Moderna Inc. and Russia’s Sputnik V both outperformed Pfizer Inc. and BioNTech SE’s version in terms of efficacy in a large-scale study of five different vaccines conducted by Hungarian researchers. Moderna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against COVID-related mortality, compared to 85.7% and 95.4%, […]
EU authorizes use of Pfizer vaccine in children from 5 to 11 years old
The drug regulator of the European Union (EU) authorized the use of the vaccine developed by Pfizer-BioNTech in children between the ages of five and 11, paving the way for the vaccination of millions of primary school students on the continent amid a widespread spike in infections across Europe. This is the first time that […]